Insmed Incorporated
Insmed Incorporated (INSM) Revenue
Annual & quarterly revenue history · segment & region breakdown
INSM · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsInsmed Incorporated trailing twelve-month (TTM) revenue is $0.82B, an increase of 66.73% year-over-year from $0.61B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.61B | +$0.24B | +66.73% |
| 2024-12-31 | $0.36B | +$0.06B | +19.17% |
| 2023-12-31 | $0.31B | +$0.06B | +24.39% |
| 2022-12-31 | $0.25B | +$0.06B | +30.19% |
| 2021-12-31 | $0.19B | +$0.02B | +14.63% |
| 2020-12-31 | $0.16B | +$0.03B | +20.48% |
| 2019-12-31 | $0.14B | +$0.13B | +1287.56% |
| 2018-12-31 | $0.01B | +$0.01B | — |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | +$0.00B | — |
Compare revenue vs peers
BiotechnologyCompare INSM revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Insmed Incorporated receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Insmed Incorporated reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Insmed Incorporated's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
INSM revenue · 4 questionsINSM's trailing twelve-month (TTM) revenue is $0.82B. That is an increase of 66.73% year-over-year from $0.61B in FY2025.
▸ Source: FMP · Insmed Incorporated SEC filings · GAAP · Insmed Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026